# Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants

> **NCT05265247** · PHASE1 · COMPLETED · sponsor: **HALEON** · enrollment: 61 (actual)

## Conditions studied

- Gastrointestinal Diseases

## Interventions

- **DRUG:** Esomeprazole 20 mg Delayed-Release Capsules
- **DRUG:** Esomeprazole 20 mg Delayed-Release Capsules (Nexium 24HR)

## Key facts

- **NCT ID:** NCT05265247
- **Lead sponsor:** HALEON
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-02
- **Primary completion:** 2022-06-02
- **Final completion:** 2022-06-02
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05265247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05265247, "Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05265247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*